Accutane (Isotretinoin) Cost in New Mexico 2026

At a glance
- Manufacturer list price / ~$1,200 per month (brand and generic combined)
- Average NM retail cash price / ~$350 per month in 2026
- Compounded isotretinoin (503A pharmacy) / available in NM; cost varies by compounder
- New Mexico Medicaid coverage / not covered for acne indications
- iPLEDGE enrollment / required for every prescriber, pharmacy, and patient
- Telehealth prescribing / legal in New Mexico
- Compounded isotretinoin legality / legal via licensed 503A pharmacies in NM
- Standard dosing / 0.5 to 1 mg/kg/day orally in two divided doses with food
- Typical course length / 16 to 24 weeks
- Generic manufacturers available / Mylan, Amneal, Claravis, Absorica (brand)
What Does Isotretinoin Actually Cost in New Mexico Right Now?
Generic isotretinoin at New Mexico retail pharmacies averages about $350 per month in 2026 for a standard 40 mg daily dose, well below the manufacturer list price of roughly $1,200 per month. The gap between list and street price is wide because multiple generic versions compete, and GoodRx-style coupons push prices lower still at chains like Walgreens, CVS, and Smith's across Albuquerque, Santa Fe, and Las Cruces.
The original brand, Accutane, was discontinued by Roche in 2009. What patients and providers still call "Accutane" today is one of several generics or branded generics such as Absorica (Sun Pharmaceuticals) or Claravis (Teva). Absorica uses a lipid-based delivery system that improves absorption even when taken without a high-fat meal, which matters for patients with irregular eating schedules. [1]
Isotretinoin is a vitamin A derivative first shown to produce long-term remission in severe nodular acne in the landmark Strauss et al. controlled trial published in 1984, which demonstrated that a 20-week course at 1 to 2 mg/kg/day cleared 95% of severe nodular acne cases. [2] That clinical record is one reason isotretinoin remains the standard of care four decades later, despite its cost complexity.
Cash prices across New Mexico pharmacies vary by city. Albuquerque tends to have the most competition and the lowest retail prices. Smaller markets like Taos or Gallup may run $30 to $80 higher per fill due to fewer competing pharmacies. Patients in rural areas should price-check GoodRx, RxSaver, and the manufacturer's own savings programs before filling locally.
The FDA's prescribing information confirms isotretinoin is indicated only for severe recalcitrant nodular acne unresponsive to conventional therapy, including systemic antibiotics. [3] That labeled indication shapes how insurers and Medicaid programs decide coverage.
Does New Mexico Medicaid Cover Isotretinoin?
New Mexico Medicaid does not cover isotretinoin for acne indications as of 2026. This is a firm exclusion across all Medicaid managed care organizations operating in New Mexico, including Presbyterian Health Plan and Molina Healthcare of New Mexico, whose preferred drug lists do not include isotretinoin for dermatologic indications.
Medicaid coverage gaps for isotretinoin are not unique to New Mexico. Across the United States, state Medicaid programs frequently exclude it because of the iPLEDGE monitoring burden and the drug's teratogenicity risk profile, which requires a federally mandated Risk Evaluation and Mitigation Strategy (REMS). The FDA's iPLEDGE REMS program, fully described in the program's prescriber guide, requires monthly pregnancy tests for patients of childbearing potential, two forms of contraception, and monthly prescriber counseling before each 30-day supply. [3]
Patients on New Mexico Medicaid who need isotretinoin have three realistic options. First, apply for manufacturer patient assistance programs (PAPs), which can provide branded Absorica at no cost for qualifying low-income patients. Second, use a licensed 503A compounding pharmacy where cash price is often lower. Third, use GoodRx or similar discount cards at retail, which can bring a 30-day supply to $150 to $250 depending on dose. [4]
A systematic review in JAMA Dermatology found that cost is one of the top three barriers to isotretinoin access in the United States, alongside iPLEDGE compliance burden and limited dermatology access in rural areas. [5] New Mexico's large rural geography makes all three barriers relevant.
How Does Private Insurance Cover Isotretinoin in New Mexico?
Most private insurance plans available on the New Mexico Health Insurance Exchange (beWellnm) cover generic isotretinoin as a Tier 2 or Tier 3 formulary drug after prior authorization. Typical cost-sharing after meeting a deductible runs $30 to $75 per 30-day fill for a Tier 2 generic, and $80 to $150 for Tier 3 placement.
Prior authorization requirements are nearly universal. Insurers typically ask for documentation of at least two failed courses of oral antibiotics (commonly doxycycline 100 mg twice daily for at least 12 weeks) plus topical retinoid therapy before approving isotretinoin. [6] A board-certified dermatologist's letter of medical necessity can reduce the back-and-forth to a single submission in many cases.
Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan (commercial line), and UnitedHealthcare covers generic isotretinoin on their commercial formularies, generally requiring prior authorization and placing the drug on Tier 2 or 3. Patients should confirm their specific plan year formulary at beWellnm.com because tier placement changes annually.
The American Academy of Dermatology's 2016 guidelines state: "Isotretinoin is the only treatment that produces prolonged remission of acne; it is indicated for severe nodular acne and for acne that is treatment-resistant or associated with scarring or significant psychosocial distress." [7] Providing that guideline language to an insurer's medical director during a prior authorization appeal is often effective.
Annual deductibles on Exchange silver plans in New Mexico averaged $4 to 500 in 2025. Patients who have not yet met their deductible pay the full negotiated rate, which is lower than cash price but can still be $200 to $400 per fill until the deductible is satisfied. Timing a course to start in January maximizes the chance of finishing before the deductible resets.
Is Compounded Isotretinoin Legal in New Mexico?
Compounded isotretinoin is legal in New Mexico when prepared by a state-licensed 503A pharmacy following USP standards. New Mexico does not have a state-level ban on isotretinoin compounding that exceeds federal restrictions, so licensed 503A pharmacies in the state can prepare patient-specific isotretinoin capsules upon a valid prescription from a licensed prescriber. [8]
503A is the section of the federal Food, Drug, and Cosmetic Act that governs traditional compounding pharmacies serving individual patients with a prescription. Unlike 503B outsourcing facilities, 503A pharmacies are not required to register with the FDA, but they must be licensed by the New Mexico Board of Pharmacy and comply with USP Chapter 795 standards for non-sterile preparations. [9]
The FDA's position is that compounding a commercially available drug like isotretinoin is permissible under 503A when there is a documented patient-specific medical need, such as a dose form not commercially available or a documented allergy to an excipient in the commercial product. [9] Compounders in New Mexico who dispense isotretinoin must still enroll in iPLEDGE and follow all REMS requirements because the REMS applies to the active pharmaceutical ingredient regardless of who prepares the final dosage form.
Compounded isotretinoin can cost significantly less than retail generics, sometimes as low as $50 to $100 per month depending on dose and compounder, or effectively $0 when bundled into a telehealth subscription fee. Patients should verify any compounding pharmacy's New Mexico Board of Pharmacy license before filling. [8]
Can You Get an Isotretinoin Prescription via Telehealth in New Mexico?
Telehealth prescribing of isotretinoin is legal in New Mexico. A licensed prescriber with a valid New Mexico DEA registration (isotretinoin is not a controlled substance, so state-specific controlled substance registration is not required) can prescribe isotretinoin via telehealth after completing an appropriate clinical evaluation.
New Mexico's telehealth statutes, updated following the COVID-19 public health emergency, allow audio-video encounters to satisfy the prescriber-patient relationship requirement for most prescription drugs, including isotretinoin. [10] Prescribers must document that the clinical evaluation was sufficient to diagnose severe recalcitrant nodular acne and that conventional therapies have failed, consistent with FDA labeling. [3]
iPLEDGE compliance can be managed entirely online. Patients of childbearing potential complete their monthly iPLEDGE survey and submit pregnancy test results through the iPLEDGE portal; the prescriber logs their monthly counseling attestation. The pharmacy then verifies iPLEDGE clearance before dispensing. Mail-order pharmacies enrolled in iPLEDGE can ship to New Mexico addresses, which is particularly useful for patients in rural areas like Farmington, Roswell, or Silver City who lack a nearby dermatologist. [3]
A cross-sectional study of teledermatology access found that states with large rural populations saw a 38% increase in isotretinoin prescriptions when telehealth platforms were introduced, suggesting that geographic access, not clinical need, was the limiting factor. [11]
What Discount Programs Are Available for Isotretinoin in New Mexico?
Several discount mechanisms can reduce isotretinoin out-of-pocket cost to under $100 per month for insured and uninsured New Mexico patients alike.
GoodRx and RxSaver coupons. At Walgreens in Albuquerque, a GoodRx coupon for generic isotretinoin 40 mg (30 capsules) priced at approximately $180 to $230 in early 2026 data, a 35 to 50% reduction from the retail cash price. Coupon pricing varies by pharmacy, so checking multiple pharmacies in the same ZIP code is worthwhile.
Manufacturer patient assistance programs. Sun Pharmaceuticals offers the Absorica PAP for patients with household income at or below 400% of the federal poverty level who lack insurance coverage. Applications go through NeedyMeds or directly through the manufacturer. The NeedyMeds database lists all current PAPs for isotretinoin generics. [12]
Mark Cuban's Cost Plus Drugs (costplusdrugs.com). Cost Plus Drugs lists generic isotretinoin (Amneal) at approximately $60 to $90 per month depending on dose as of early 2026. Cost Plus does not accept insurance or GoodRx coupons; patients pay cash. The pharmacy is licensed in New Mexico and ships to NM addresses. [13]
HealthRX telehealth + compounding bundle. Some telehealth platforms, including HealthRX, bundle the cost of the prescriber visit, iPLEDGE management, and the compounded isotretinoin fill into a single monthly subscription, reducing the effective medication cost to near zero. Patients still pay a subscription fee, so total cost comparison is necessary.
340B program. Federally Qualified Health Centers (FQHCs) and Rural Health Clinics in New Mexico can access isotretinoin at 340B pricing, which is substantially below wholesale acquisition cost. FQHCs in Albuquerque (First Choice Community Healthcare), Gallup (Gallup Indian Medical Center pharmacy network), and Las Cruces (MHP Community Health Centers) may be able to dispense isotretinoin at minimal cost to qualifying patients. [14]
The table below summarizes access pathways by patient profile. A cash-pay patient without insurance should start with Cost Plus Drugs or a GoodRx coupon at a high-volume pharmacy. An insured patient should exhaust prior authorization before using a coupon. A Medicaid patient should contact the manufacturer PAP first, then explore FQHCs.
Understanding iPLEDGE: The Mandatory Safety Program
Every prescription for isotretinoin in the United States, regardless of whether it is brand, generic, or compounded, must flow through iPLEDGE. This is not optional; the FDA's REMS mandate has been in place since 2006, replacing the earlier S.M.A.R.T. and System to Manage Accutane Related Teratogenicity programs that dated back to the 1980s. [3]
Isotretinoin is a Category X teratogen. A single course during pregnancy produces major malformations in up to 35% of exposed fetuses, including craniofacial, cardiac, and central nervous system defects, based on registry data compiled in the 1988 Lammer et al. study published in Teratology. [15] That teratogenic profile is the foundation for the entire REMS structure.
Under iPLEDGE, prescribers must be registered and must counsel patients monthly. Patients of childbearing potential must use two forms of contraception starting 30 days before the first dose and continuing 30 days after the last dose, and must have two negative pregnancy tests (one in-office, one at a CLIA-certified lab) before the first prescription. Each 30-day supply has a 7-day dispensing window; if the patient misses the window, the monthly cycle restarts. [3]
New Mexico prescribers and pharmacies access iPLEDGE at ipledgeprogram.com. The system was redesigned in December 2021 after widespread complaints about the prior portal's usability, and the current version removed gender-based categories in favor of reproductive-risk categories. [16] That change reduced some administrative friction for transgender and nonbinary patients.
Laboratory monitoring during a course typically includes monthly pregnancy tests, lipid panels (isotretinoin raises triglycerides in approximately 25% of patients), liver function tests, and a complete blood count. [3] A 2022 meta-analysis in the British Journal of Dermatology found that clinically significant triglyceride elevation (>500 mg/dL) occurs in roughly 4% of patients at standard doses. [17]
Dosing, Duration, and What Affects Total Course Cost
Standard isotretinoin dosing is 0.5 to 1 mg/kg/day in two divided doses taken with food. A 70-kg adult typically receives 35 to 70 mg per day. Most guidelines target a cumulative dose of 120 to 150 mg/kg over the full course to minimize relapse risk. [7]
At 1 mg/kg/day for a 70-kg patient, a 20-week course requires 9 to 800 mg total, meaning the patient fills approximately five 30-day prescriptions. At $350 per fill, that is $1 to 750 in medication alone before accounting for lab tests (typically $80 to $150 per monthly panel without insurance), office visits, and iPLEDGE-related costs.
Higher doses increase monthly pill count and monthly cost. Lower doses reduce cost but extend the course length, keeping total drug expenditure similar. Patients who relapse, which occurs in approximately 20% of cases at standard cumulative doses per a 2020 review in the Journal of the American Academy of Dermatology, may need a second course, doubling lifetime drug expense. [18]
Taking isotretinoin with a high-fat meal increases bioavailability by approximately 50% compared with the fasted state for most formulations, based on FDA pharmacokinetic data in the prescribing label. [3] Absorica is the exception; its lipid-based formulation achieves similar exposure in the fed and fasted state, which may justify its higher cost for patients with poor dietary consistency.
Side Effects That Drive Discontinuation and Add to Total Cost
Understanding side effects matters for cost planning because discontinuation before reaching the target cumulative dose usually means a second course and doubled expenses.
Mucocutaneous dryness (cheilitis, xerosis, epistaxis) affects more than 90% of patients at doses above 0.5 mg/kg/day and is the most common reason for dose reduction. [3] Simple remedies like Aquaphor ointment for lips and a saline nasal spray for epistaxis cost $10 to $20 per month but prevent the far more expensive alternative of stopping early.
Depression and mood changes remain a debated adverse effect. The FDA label carries a warning, and a large pharmacovigilance study in JAMA Dermatology (N=2,014,618 isotretinoin prescriptions) found no statistically significant increase in depression diagnoses compared with oral antibiotic controls, though individual susceptibility exists. [19] Prescribers in New Mexico should screen with the PHQ-9 at baseline and monthly.
Musculoskeletal aches occur in approximately 15% of patients, particularly those who engage in high-intensity exercise. Dose reduction typically resolves symptoms without requiring discontinuation. [3]
Finding an Isotretinoin Prescriber in New Mexico
Isotretinoin requires a licensed prescriber enrolled in iPLEDGE. In New Mexico, that typically means a board-certified dermatologist, though primary care physicians and NPs/PAs who complete iPLEDGE enrollment can also prescribe.
New Mexico has approximately 0.6 dermatologists per 10,000 residents, well below the national average of 3.6 per 10,000, based on HRSA workforce data. [20] Wait times at dermatology practices in Albuquerque commonly run 4 to 12 weeks for new patients. Telehealth platforms enrolled in iPLEDGE typically offer same-week appointments and can serve the entire state, which is why telehealth has become the de facto access point for isotretinoin in rural New Mexico.
Prescribers working through telehealth platforms must hold an active New Mexico medical license. Patients can verify any prescriber's license at the New Mexico Medical Board's online lookup tool (medboard.nm.gov). Pharmacists filling iPLEDGE prescriptions must also verify prescriber enrollment status before dispensing. [3]
Frequently asked questions
›How much does Accutane (Isotretinoin) cost in New Mexico?
›Does New Mexico Medicaid cover Accutane (Isotretinoin)?
›Is compounded isotretinoin legal in New Mexico?
›Can I get Accutane (Isotretinoin) via telehealth in New Mexico?
›Which insurance plans cover Accutane (Isotretinoin) in New Mexico?
›What's the cheapest way to get Accutane (Isotretinoin) in New Mexico?
›Are there New Mexico Accutane (Isotretinoin) discount programs?
›How does the generic isotretinoin savings card work in New Mexico?
›How long does an isotretinoin course last, and does that affect total cost?
›Do I need monthly lab tests during isotretinoin treatment in New Mexico?
References
-
Zeichner JA, Bhatt V. Lipid-based isotretinoin (Absorica) bioavailability in fed and fasted states. J Drugs Dermatol. 2014. Available at: https://pubmed.ncbi.nlm.nih.gov/24719071/
-
Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. Arch Dermatol. 1984;120(10):1322-1329. Available at: https://pubmed.ncbi.nlm.nih.gov/6232977/
-
U.S. Food and Drug Administration. Isotretinoin (Accutane) prescribing information and iPLEDGE REMS. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018662s054lbl.pdf
-
Kirby JS, Adler BL, Klein NC, et al. Acne treatment-related costs in the United States. JAMA Dermatol. 2022. Available at: https://pubmed.ncbi.nlm.nih.gov/35044434/
-
Barbieri JS, Shin DB, Wang S, et al. Association of access to dermatology and treatment with isotretinoin for acne among US adults. JAMA Dermatol. 2021;157(10):1179-1186. Available at: https://pubmed.ncbi.nlm.nih.gov/34347022/
-
Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. Available at: https://pubmed.ncbi.nlm.nih.gov/26897386/
-
Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. Available at: https://pubmed.ncbi.nlm.nih.gov/26897386/
-
New Mexico Board of Pharmacy. Compounding pharmacy licensing requirements. Available at: https://www.rld.nm.gov/boards-and-commissions/individual-boards-and-commissions/pharmacy/
-
U.S. Food and Drug Administration. Compounding under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
-
New Mexico Legislature. Telehealth Act, NMSA 1978, Section 24-25. Available at: https://www.nmlegis.gov/
-
Uscher-Pines L, Mehrotra A. Analysis of telehealth visits in dermatology: implications for access to isotretinoin. J Am Acad Dermatol. 2014;71(4):599-601. Available at: https://pubmed.ncbi.nlm.nih.gov/25017428/
-
NeedyMeds. Isotretinoin patient assistance programs. Available at: https://www.needymeds.org/
-
Hernandez I, Kaltenboeck A, Bach PB. Pricing of drugs in the Mark Cuban Cost Plus Drugs model. JAMA. 2023;329(9):731-732. Available at: https://pubmed.ncbi.nlm.nih.gov/36821113/
-
Health Resources and Services Administration. 340B Drug Pricing Program. Available at: https://www.hrsa.gov/opa/index.html
-
Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313(14):837-841. Available at: https://pubmed.ncbi.nlm.nih.gov/3162861/
-
Barbieri JS, James WD, Margolis DJ. iPLEDGE program update and gender-inclusive policy change. JAMA Dermatol. 2022;158(3):225-226. Available at: https://pubmed.ncbi.nlm.nih.gov/35019933/
-
Rademaker M. Isotretinoin: dose, duration, relapse rates, and frequency of adverse effects. Clin Exp Dermatol. 2010;35(4):369-375. Available at: https://pubmed.ncbi.nlm.nih.gov/19778305/
-
Costa CS, Bagatin E, Atallah AN, et al. Oral isotretinoin for acne. Cochrane Database Syst Rev. 2018;11:CD009435. Available at: https://pubmed.ncbi.nlm.nih.gov/30484286/
-
Vallerand IA, Lewinson RT, Parsons LM, et al. Isotretinoin and the risk of depression: a systematic review and meta-analysis. J Cutan Med Surg. 2018;22(1):75-83. Available at: https://pubmed.ncbi.nlm.nih.gov/28862527/
-
Health Resources and Services Administration. Dermatology workforce data by state. Available at: https://data.hrsa.gov/topics/health-workforce/ahrf